<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38118002</PMID><DateCompleted><Year>2024</Year><Month>03</Month><Day>22</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>06</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1362-4962</ISSN><JournalIssue CitedMedium="Internet"><Volume>52</Volume><Issue>5</Issue><PubDate><Year>2024</Year><Month>Mar</Month><Day>21</Day></PubDate></JournalIssue><Title>Nucleic acids research</Title><ISOAbbreviation>Nucleic Acids Res</ISOAbbreviation></Journal><ArticleTitle>Histone lactylation-boosted ALKBH3 potentiates tumor progression and diminished promyelocytic leukemia protein nuclear condensates by m1A demethylation of SP100A.</ArticleTitle><Pagination><StartPage>2273</StartPage><EndPage>2289</EndPage><MedlinePgn>2273-2289</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/nar/gkad1193</ELocationID><Abstract><AbstractText>Albeit N1-Methyladenosine (m1A) RNA modification represents an important regulator of RNA metabolism, the role of m1A modification in carcinogenesis remains enigmatic. Herein, we found that histone lactylation enhances ALKBH3 expression and simultaneously attenuates the formation of tumor-suppressive promyelocytic leukemia protein (PML) condensates by removing the m1A methylation of SP100A, promoting the malignant transformation of cancers. First, ALKBH3 is specifically upregulated in high-risk ocular melanoma due to excessive histone lactylation levels, referring to m1A hypomethylation status. Moreover, the multiomics analysis subsequently identified that SP100A, a core component for PML bodies, serves as a downstream candidate target for ALKBH3. Therapeutically, the silencing of ALKBH3 exhibits efficient therapeutic efficacy in melanoma both in vitro and in vivo, which could be reversed by the depletion of SP100A. Mechanistically, we found that YTHDF1 is responsible for recognition of the m1A methylated SP100A transcript, which increases its RNA stability and translational efficacy. Conclusively, we initially demonstrated that m1A modification is necessary for tumor suppressor gene expression, expanding the current understandings of dynamic m1A function during tumor progression. In addition, our results indicate that lactylation-driven ALKBH3 is essential for the formation of PML nuclear condensates, which bridges our knowledge of m1A modification, metabolic reprogramming, and phase-separation events.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2023. Published by Oxford University Press on behalf of Nucleic Acids Research.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gu</LastName><ForeName>Xiang</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai&#xa0;200011, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhuang</LastName><ForeName>Ai</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai&#xa0;200011, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Jie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai&#xa0;200011, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Ludi</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai&#xa0;200011, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ge</LastName><ForeName>Shengfang</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai&#xa0;200011, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruan</LastName><ForeName>Jing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai&#xa0;200011, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jia</LastName><ForeName>Renbing</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai&#xa0;200011, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fan</LastName><ForeName>Xianqun</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0002-9394-3969</Identifier><AffiliationInfo><Affiliation>Department of Ophthalmology, Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai&#xa0;200011, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chai</LastName><ForeName>Peiwei</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-9135-0940</Identifier><AffiliationInfo><Affiliation>Department of Ophthalmology, Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai&#xa0;200011, People's Republic of China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>82373298</GrantID><Agency>National Natural Science Foundation of China</Agency><Country/></Grant><Grant><GrantID>20DZ2270800</GrantID><Agency>Science and Technology Commission of Shanghai</Agency><Country/></Grant><Grant><GrantID>2023M732290</GrantID><Agency>China Postdoctoral Science Foundation</Agency><Country/></Grant><Grant><GrantID>2022ZZ01003</GrantID><Agency>Shanghai Key Clinical Specialty, Shanghai Eye Disease Research Center</Agency><Country/></Grant><Grant><GrantID>SHSMU-ZDCX20210900</GrantID><Agency>Innovative Research Team of High-level Local Universities in Shanghai</Agency><Country/></Grant><Grant><GrantID>GWVI-11.2-YQ19</GrantID><Agency>Shanghai Municipal Health Commission</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nucleic Acids Res</MedlineTA><NlmUniqueID>0411011</NlmUniqueID><ISSNLinking>0305-1048</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 1.14.11.-</RegistryNumber><NameOfSubstance UI="D000071500">AlkB Homolog 3, Alpha-Ketoglutarate-Dependent Dioxygenase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.14.11.-</RegistryNumber><NameOfSubstance UI="C486439">ALKBH3 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006657">Histones</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000071156">Promyelocytic Leukemia Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>63231-63-0</RegistryNumber><NameOfSubstance UI="D012313">RNA</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014157">Transcription Factors</NameOfSubstance></Chemical><Chemical><RegistryNumber>135844-47-2</RegistryNumber><NameOfSubstance UI="C066642">SP100 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D034961">Antigens, Nuclear</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001324">Autoantigens</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071500" MajorTopicYN="Y">AlkB Homolog 3, Alpha-Ketoglutarate-Dependent Dioxygenase</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073398" MajorTopicYN="N">Demethylation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019175" MajorTopicYN="N">DNA Methylation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006657" MajorTopicYN="Y">Histones</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008545" MajorTopicYN="Y">Melanoma</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071156" MajorTopicYN="N">Promyelocytic Leukemia Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012313" MajorTopicYN="N">RNA</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014157" MajorTopicYN="N">Transcription Factors</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D034961" MajorTopicYN="Y">Antigens, Nuclear</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001324" MajorTopicYN="Y">Autoantigens</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005134" MajorTopicYN="Y">Eye Neoplasms</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>12</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>11</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>6</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>3</Month><Day>22</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>12</Month><Day>20</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>12</Month><Day>20</Day><Hour>15</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>12</Month><Day>20</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38118002</ArticleId><ArticleId IdType="pmc">PMC10954454</ArticleId><ArticleId IdType="doi">10.1093/nar/gkad1193</ArticleId><ArticleId IdType="pii">7481829</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Barbieri &#xa0;I., Kouzarides &#xa0;T. &#xa0;Role of RNA modifications in cancer. Nat. Rev. Cancer. 2020; 20:303&#x2013;322.</Citation><ArticleIdList><ArticleId IdType="pubmed">32300195</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao &#xa0;B.S., Roundtree &#xa0;I.A., He &#xa0;C. &#xa0;Post-transcriptional gene regulation by mRNA modifications. Nat. Rev. Mol. Cell Biol. &#xa0;2017; 18:31&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5167638</ArticleId><ArticleId IdType="pubmed">27808276</ArticleId></ArticleIdList></Reference><Reference><Citation>Boriack-Sjodin &#xa0;P.A., Ribich &#xa0;S., Copeland &#xa0;R.A. &#xa0;RNA-modifying proteins as anticancer drug targets. Nat. Rev. Drug Discov. &#xa0;2018; 17:435&#x2013;453.</Citation><ArticleIdList><ArticleId IdType="pubmed">29773918</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi &#xa0;J., Indrisiunaite &#xa0;G., DeMirci &#xa0;H., Ieong &#xa0;K.W., Wang &#xa0;J., Petrov &#xa0;A., Prabhakar &#xa0;A., Rechavi &#xa0;G., Dominissini &#xa0;D., He &#xa0;C. &#xa0;et al. . &#xa0;2'-O-methylation in mRNA disrupts tRNA decoding during translation elongation. Nat. Struct. Mol. Biol. &#xa0;2018; 25:208&#x2013;216.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5840002</ArticleId><ArticleId IdType="pubmed">29459784</ArticleId></ArticleIdList></Reference><Reference><Citation>Han &#xa0;X., Wang &#xa0;M., Zhao &#xa0;Y.L., Yang &#xa0;Y., Yang &#xa0;Y.G. &#xa0;RNA methylations in human cancers. Semin. Cancer Biol. &#xa0;2021; 75:97&#x2013;115.</Citation><ArticleIdList><ArticleId IdType="pubmed">33220459</ArticleId></ArticleIdList></Reference><Reference><Citation>Safra &#xa0;M., Sas-Chen &#xa0;A., Nir &#xa0;R., Winkler &#xa0;R., Nachshon &#xa0;A., Bar-Yaacov &#xa0;D., Erlacher &#xa0;M., Rossmanith &#xa0;W., Stern-Ginossar &#xa0;N., Schwartz &#xa0;S. &#xa0;The m1A landscape on cytosolic and mitochondrial mRNA at single-base resolution. Nature. 2017; 551:251&#x2013;255.</Citation><ArticleIdList><ArticleId IdType="pubmed">29072297</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu &#xa0;F., Clark &#xa0;W., Luo &#xa0;G., Wang &#xa0;X., Fu &#xa0;Y., Wei &#xa0;J., Wang &#xa0;X., Hao &#xa0;Z., Dai &#xa0;Q., Zheng &#xa0;G. &#xa0;et al. . &#xa0;ALKBH1-mediated tRNA demethylation regulates translation. Cell. 2016; 167:816&#x2013;828.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5119773</ArticleId><ArticleId IdType="pubmed">27745969</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang &#xa0;Y., Wang &#xa0;J., Li &#xa0;X., Xiong &#xa0;X., Wang &#xa0;J., Zhou &#xa0;Z., Zhu &#xa0;X., Gu &#xa0;Y., Dominissini &#xa0;D., He &#xa0;L. &#xa0;et al. . &#xa0;N(1)-methyladenosine methylation in tRNA drives liver tumourigenesis by regulating cholesterol metabolism. Nat. Commun. &#xa0;2021; 12:6314.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8563902</ArticleId><ArticleId IdType="pubmed">34728628</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu &#xa0;Y., Chen &#xa0;Z., Xie &#xa0;G., Zhang &#xa0;H., Wang &#xa0;Z., Zhou &#xa0;J., Chen &#xa0;F., Li &#xa0;J., Chen &#xa0;L., Niu &#xa0;H. &#xa0;et al. . &#xa0;RNA m(1)A methylation regulates glycolysis of cancer cells through modulating ATP5D. Proc. Natl. Acad. Sci. U.S.A. &#xa0;2022; 119:e2119038119.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9282374</ArticleId><ArticleId IdType="pubmed">35867754</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuang &#xa0;W., Jin &#xa0;H., Yang &#xa0;F., Chen &#xa0;X., Liu &#xa0;J., Li &#xa0;T., Chang &#xa0;Y., Liu &#xa0;M., Xu &#xa0;Z., Huo &#xa0;C. &#xa0;et al. . &#xa0;ALKBH3-dependent m(1)A demethylation of Aurora A mRNA inhibits ciliogenesis. Cell Discov. &#xa0;2022; 8:25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8917145</ArticleId><ArticleId IdType="pubmed">35277482</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao &#xa0;Y., Zhao &#xa0;Q., Kaboli &#xa0;P.J., Shen &#xa0;J., Li &#xa0;M., Wu &#xa0;X., Yin &#xa0;J., Zhang &#xa0;H., Wu &#xa0;Y., Lin &#xa0;L. &#xa0;et al. . &#xa0;m1A regulated genes modulate PI3K/AKT/mTOR and ErbB pathways in gastrointestinal cancer. Transl Oncol. 2019; 12:1323&#x2013;1333.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6661385</ArticleId><ArticleId IdType="pubmed">31352195</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao &#xa0;L., Chen &#xa0;R., Sugimoto &#xa0;M., Mizuta &#xa0;M., Kishimoto &#xa0;Y., Omori &#xa0;K. &#xa0;The impact of m1A methylation modification patterns on tumor immune microenvironment and prognosis in oral squamous cell carcinoma. Int. J. Mol. Sci. &#xa0;2021; 22:10302.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8508946</ArticleId><ArticleId IdType="pubmed">34638642</ArticleId></ArticleIdList></Reference><Reference><Citation>Pier &#xa0;G.B., Thomas &#xa0;D.M. &#xa0;Characterization of the human immune response to a polysaccharide vaccine from Pseudomonas aeruginosa. J. Infect. Dis. &#xa0;1983; 148:206&#x2013;213.</Citation><ArticleIdList><ArticleId IdType="pubmed">6411830</ArticleId></ArticleIdList></Reference><Reference><Citation>Esteve-Puig &#xa0;R., Climent &#xa0;F., Pi&#xf1;eyro &#xa0;D., Domingo-Dom&#xe8;nech &#xa0;E., Davalos &#xa0;V., Encuentra &#xa0;M., Rea &#xa0;A., Espejo-Herrera &#xa0;N., Soler &#xa0;M., Lopez &#xa0;M. &#xa0;et al. . &#xa0;Epigenetic loss of m1A RNA demethylase ALKBH3 in Hodgkin lymphoma targets collagen, conferring poor clinical outcome. Blood. 2021; 137:994&#x2013;999.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7918181</ArticleId><ArticleId IdType="pubmed">32915956</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen &#xa0;Z., Qi &#xa0;M., Shen &#xa0;B., Luo &#xa0;G., Wu &#xa0;Y., Li &#xa0;J., Lu &#xa0;Z., Zheng &#xa0;Z., Dai &#xa0;Q., Wang &#xa0;H. &#xa0;Transfer RNA demethylase ALKBH3 promotes cancer progression via induction of tRNA-derived small RNAs. Nucleic Acids Res. &#xa0;2019; 47:2533&#x2013;2545.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6411830</ArticleId><ArticleId IdType="pubmed">30541109</ArticleId></ArticleIdList></Reference><Reference><Citation>Li &#xa0;X., Xiong &#xa0;X., Wang &#xa0;K., Wang &#xa0;L., Shu &#xa0;X., Ma &#xa0;S., Yi &#xa0;C. &#xa0;Transcriptome-wide mapping reveals reversible and dynamic N(1)-methyladenosine methylome. Nat. Chem. Biol. &#xa0;2016; 12:311&#x2013;316.</Citation><ArticleIdList><ArticleId IdType="pubmed">26863410</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou &#xa0;H., Rauch &#xa0;S., Dai &#xa0;Q., Cui &#xa0;X., Zhang &#xa0;Z., Nachtergaele &#xa0;S., Sepich &#xa0;C., He &#xa0;C., Dickinson &#xa0;B.C. &#xa0;Evolution of a reverse transcriptase to map N(1)-methyladenosine in human messenger RNA. Nat. Methods. 2019; 16:1281&#x2013;1288.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6884687</ArticleId><ArticleId IdType="pubmed">31548705</ArticleId></ArticleIdList></Reference><Reference><Citation>Griewank &#xa0;K.G., Westekemper &#xa0;H., Murali &#xa0;R., Mach &#xa0;M., Schilling &#xa0;B., Wiesner &#xa0;T., Schimming &#xa0;T., Livingstone &#xa0;E., Sucker &#xa0;A., Grabellus &#xa0;F. &#xa0;et al. . &#xa0;Conjunctival melanomas harbor BRAF and NRAS mutations and copy number changes similar to cutaneous and mucosal melanomas. Clin. Cancer Res. &#xa0;2013; 19:3143&#x2013;3152.</Citation><ArticleIdList><ArticleId IdType="pubmed">23633454</ArticleId></ArticleIdList></Reference><Reference><Citation>Jager &#xa0;M.J., Shields &#xa0;C.L., Cebulla &#xa0;C.M., Abdel-Rahman &#xa0;M.H., Grossniklaus &#xa0;H.E., Stern &#xa0;M.H., Carvajal &#xa0;R.D., Belfort &#xa0;R.N., Jia &#xa0;R., Shields &#xa0;J.A. &#xa0;et al. . &#xa0;Uveal melanoma. Nat. Rev. Dis. Primers. 2020; 6:24.</Citation><ArticleIdList><ArticleId IdType="pubmed">32273508</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia &#xa0;R., Chai &#xa0;P., Wang &#xa0;S., Sun &#xa0;B., Xu &#xa0;Y., Yang &#xa0;Y., Ge &#xa0;S., Jia &#xa0;R., Yang &#xa0;Y.G., Fan &#xa0;X. &#xa0;m(6)A modification suppresses ocular melanoma through modulating HINT2 mRNA translation. Mol. Cancer. 2019; 18:161.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6854757</ArticleId><ArticleId IdType="pubmed">31722709</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu &#xa0;J., Chai &#xa0;P., Xie &#xa0;M., Ge &#xa0;S., Ruan &#xa0;J., Fan &#xa0;X., Jia &#xa0;R. &#xa0;Histone lactylation drives oncogenesis by facilitating m(6)A reader protein YTHDF2 expression in ocular melanoma. Genome Biol. &#xa0;2021; 22:85.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7962360</ArticleId><ArticleId IdType="pubmed">33726814</ArticleId></ArticleIdList></Reference><Reference><Citation>Chai &#xa0;P., Yu &#xa0;J., Jia &#xa0;R., Wen &#xa0;X., Ding &#xa0;T., Zhang &#xa0;X., Ni &#xa0;H., Jia &#xa0;R., Ge &#xa0;S., Zhang &#xa0;H. &#xa0;et al. . &#xa0;Generation of onco-enhancer enhances chromosomal remodeling and accelerates tumorigenesis. Nucleic Acids Res. &#xa0;2020; 48:12135&#x2013;12150.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7708045</ArticleId><ArticleId IdType="pubmed">33196849</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaya-Okur &#xa0;H.S., Wu &#xa0;S.J., Codomo &#xa0;C.A., Pledger &#xa0;E.S., Bryson &#xa0;T.D., Henikoff &#xa0;J.G., Ahmad &#xa0;K., Henikoff &#xa0;S. &#xa0;CUT&amp;Tag for efficient epigenomic profiling of small samples and single cells. Nat. Commun. &#xa0;2019; 10:1930.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6488672</ArticleId><ArticleId IdType="pubmed">31036827</ArticleId></ArticleIdList></Reference><Reference><Citation>Kechin &#xa0;A., Boyarskikh &#xa0;U., Kel &#xa0;A., Filipenko &#xa0;M. &#xa0;cutPrimers: a New Tool for Accurate Cutting of Primers from Reads of Targeted Next Generation Sequencing. J. Comput. Biol. &#xa0;2017; 24:1138&#x2013;1143.</Citation><ArticleIdList><ArticleId IdType="pubmed">28715235</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim &#xa0;D., Langmead &#xa0;B., Salzberg &#xa0;S.L. &#xa0;HISAT: a fast spliced aligner with low memory requirements. Nat. Methods. 2015; 12:357&#x2013;360.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4655817</ArticleId><ArticleId IdType="pubmed">25751142</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu &#xa0;T. &#xa0;Use model-based Analysis of ChIP-Seq (MACS) to analyze short reads generated by sequencing protein-DNA interactions in embryonic stem cells. Methods Mol. Biol. &#xa0;2014; 1150:81&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pubmed">24743991</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen &#xa0;L., Shao &#xa0;N.Y., Liu &#xa0;X., Maze &#xa0;I., Feng &#xa0;J., Nestler &#xa0;E.J. &#xa0;diffReps: detecting differential chromatin modification sites from ChIP-seq data with biological replicates. PLoS One. 2013; 8:e65598.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3677880</ArticleId><ArticleId IdType="pubmed">23762400</ArticleId></ArticleIdList></Reference><Reference><Citation>Xi &#xa0;Y., Liu &#xa0;M., Xu &#xa0;S., Hong &#xa0;H., Chen &#xa0;M., Tian &#xa0;L., Xie &#xa0;J., Deng &#xa0;P., Zhou &#xa0;C., Zhang &#xa0;L. &#xa0;et al. . &#xa0;Inhibition of SERPINA3N-dependent neuroinflammation is essential for melatonin to ameliorate trimethyltin chloride-induced neurotoxicity. J. Pineal Res. &#xa0;2019; 67:e12596.</Citation><ArticleIdList><ArticleId IdType="pubmed">31332839</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang &#xa0;D., Tang &#xa0;Z., Huang &#xa0;H., Zhou &#xa0;G., Cui &#xa0;C., Weng &#xa0;Y., Liu &#xa0;W., Kim &#xa0;S., Lee &#xa0;S., Perez-Neut &#xa0;M. &#xa0;et al. . &#xa0;Metabolic regulation of gene expression by histone lactylation. Nature. 2019; 574:575&#x2013;580.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6818755</ArticleId><ArticleId IdType="pubmed">31645732</ArticleId></ArticleIdList></Reference><Reference><Citation>Li &#xa0;X., Xiong &#xa0;X., Zhang &#xa0;M., Wang &#xa0;K., Chen &#xa0;Y., Zhou &#xa0;J., Mao &#xa0;Y., Lv &#xa0;J., Yi &#xa0;D., Chen &#xa0;X.W. &#xa0;et al. . &#xa0;Base-resolution mapping reveals distinct m(1)A methylome in nuclear- and mitochondrial-encoded transcripts. Mol. Cell. 2017; 68:993&#x2013;1005.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5722686</ArticleId><ArticleId IdType="pubmed">29107537</ArticleId></ArticleIdList></Reference><Reference><Citation>Jinesh &#xa0;G.G., Smallin &#xa0;M.T., Mtchedlidze &#xa0;N., Godwin &#xa0;I., Napoli &#xa0;M., Hackel &#xa0;N., Phadke &#xa0;M.S., Deshpande &#xa0;A.A., Li &#xa0;X., Lockhart &#xa0;J.H. &#xa0;et al. . &#xa0;C19MC miRNA-520G induces SP100 antiviral gene transcription and inhibits melanin production in skin cutaneous melanoma. Genes Dis. 2024; 11:60&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10425800</ArticleId><ArticleId IdType="pubmed">37588194</ArticleId></ArticleIdList></Reference><Reference><Citation>Held-Feindt &#xa0;J., Hattermann &#xa0;K., Knerlich-Lukoschus &#xa0;F., Mehdorn &#xa0;H.M., Mentlein &#xa0;R. &#xa0;SP100 reduces malignancy of human glioma cells. Int. J. Oncol. &#xa0;2011; 38:1023&#x2013;1030.</Citation><ArticleIdList><ArticleId IdType="pubmed">21274506</ArticleId></ArticleIdList></Reference><Reference><Citation>Chudasama &#xa0;P., Mughal &#xa0;S.S., Sanders &#xa0;M.A., H&#xfc;bschmann &#xa0;D., Chung &#xa0;I., Deeg &#xa0;K.I., Wong &#xa0;S.H., Rabe &#xa0;S., Hlevnjak &#xa0;M., Zapatka &#xa0;M. &#xa0;et al. . &#xa0;Integrative genomic and transcriptomic analysis of leiomyosarcoma. Nat. Commun. &#xa0;2018; 9:144.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5762758</ArticleId><ArticleId IdType="pubmed">29321523</ArticleId></ArticleIdList></Reference><Reference><Citation>Yordy &#xa0;J.S., Li &#xa0;R., Sementchenko &#xa0;V.I., Pei &#xa0;H., Muise-Helmericks &#xa0;R.C., Watson &#xa0;D.K. &#xa0;SP100 expression modulates ETS1 transcriptional activity and inhibits cell invasion. Oncogene. 2004; 23:6654&#x2013;6665.</Citation><ArticleIdList><ArticleId IdType="pubmed">15247905</ArticleId></ArticleIdList></Reference><Reference><Citation>Li &#xa0;W., Shang &#xa0;C., Guan &#xa0;C., Zhang &#xa0;Y., Sun &#xa0;K., Fu &#xa0;W. &#xa0;Low expression of Sp100 in laryngeal cancer: correlation with cell differentiation. Med. Sci. Monit. &#xa0;2010; 16:Br174&#x2013;BR178.</Citation><ArticleIdList><ArticleId IdType="pubmed">20512085</ArticleId></ArticleIdList></Reference><Reference><Citation>Negorev &#xa0;D.G., Vladimirova &#xa0;O.V., Ivanov &#xa0;A., Rauscher &#xa0;F. &#xa0;3rd, Maul &#xa0;G.G. &#xa0;Differential role of Sp100 isoforms in interferon-mediated repression of herpes simplex virus type 1 immediate-early protein expression. J. Virol. &#xa0;2006; 80:8019&#x2013;8029.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1563809</ArticleId><ArticleId IdType="pubmed">16873258</ArticleId></ArticleIdList></Reference><Reference><Citation>Seeler &#xa0;J.S., Marchio &#xa0;A., Sitterlin &#xa0;D., Transy &#xa0;C., Dejean &#xa0;A. &#xa0;Interaction of SP100 with HP1 proteins: a link between the promyelocytic leukemia-associated nuclear bodies and the chromatin compartment. Proc. Natl. Acad. Sci. U.S.A. &#xa0;1998; 95:7316&#x2013;7321.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC22602</ArticleId><ArticleId IdType="pubmed">9636146</ArticleId></ArticleIdList></Reference><Reference><Citation>Durante &#xa0;M.A., Rodriguez &#xa0;D.A., Kurtenbach &#xa0;S., Kuznetsov &#xa0;J.N., Sanchez &#xa0;M.I., Decatur &#xa0;C.L., Snyder &#xa0;H., Feun &#xa0;L.G., Livingstone &#xa0;A.S., Harbour &#xa0;J.W. &#xa0;Single-cell analysis reveals new evolutionary complexity in uveal melanoma. Nat. Commun. &#xa0;2020; 11:496.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6981133</ArticleId><ArticleId IdType="pubmed">31980621</ArticleId></ArticleIdList></Reference><Reference><Citation>Corpet &#xa0;A., Kleijwegt &#xa0;C., Roubille &#xa0;S., Juillard &#xa0;F., Jacquet &#xa0;K., Texier &#xa0;P., Lomonte &#xa0;P. &#xa0;PML nuclear bodies and chromatin dynamics: catch me if you can!. Nucleic Acids Res. &#xa0;2020; 48:11890&#x2013;11912.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7708061</ArticleId><ArticleId IdType="pubmed">33068409</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu &#xa0;P., Roizman &#xa0;B. &#xa0;The SP100 component of ND10 enhances accumulation of PML and suppresses replication and the assembly of HSV replication compartments. Proc. Natl. Acad. Sci. U.S.A. &#xa0;2017; 114:E3823&#x2013;E3829.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5441741</ArticleId><ArticleId IdType="pubmed">28439026</ArticleId></ArticleIdList></Reference><Reference><Citation>Milovic-Holm &#xa0;K., Krieghoff &#xa0;E., Jensen &#xa0;K., Will &#xa0;H., Hofmann &#xa0;T.G. &#xa0;FLASH links the CD95 signaling pathway to the cell nucleus and nuclear bodies. EMBO J. &#xa0;2007; 26:391&#x2013;401.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1783462</ArticleId><ArticleId IdType="pubmed">17245429</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren &#xa0;W., Yuan &#xa0;Y., Li &#xa0;Y., Mutti &#xa0;L., Peng &#xa0;J., Jiang &#xa0;X. &#xa0;The function and clinical implication of YTHDF1 in the human system development and cancer. Biomark. Res. &#xa0;2023; 11:5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9847098</ArticleId><ArticleId IdType="pubmed">36650570</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai &#xa0;X., Wang &#xa0;T., Gonzalez &#xa0;G., Wang &#xa0;Y. &#xa0;Identification of YTH domain-containing proteins as the readers for N1-methyladenosine in RNA. Anal. Chem. &#xa0;2018; 90:6380&#x2013;6384.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6157021</ArticleId><ArticleId IdType="pubmed">29791134</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu &#xa0;Y., He &#xa0;X., Wang &#xa0;S., Sun &#xa0;B., Jia &#xa0;R., Chai &#xa0;P., Li &#xa0;F., Yang &#xa0;Y., Ge &#xa0;S., Jia &#xa0;R. &#xa0;et al. . &#xa0;The m(6)A reading protein YTHDF3 potentiates tumorigenicity of cancer stem-like cells in ocular melanoma through facilitating CTNNB1 translation. Oncogene. 2022; 41:1281&#x2013;1297.</Citation><ArticleIdList><ArticleId IdType="pubmed">35110680</ArticleId></ArticleIdList></Reference><Reference><Citation>Woo &#xa0;H.H., Chambers &#xa0;S.K. &#xa0;Human ALKBH3-induced m(1)A demethylation increases the CSF-1 mRNA stability in breast and ovarian cancer cells. Biochim Biophys Acta Gene Regul Mech. 2019; 1862:35&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pubmed">30342176</ArticleId></ArticleIdList></Reference><Reference><Citation>Izzo &#xa0;L.T., Wellen &#xa0;K.E. &#xa0;Histone lactylation links metabolism and gene regulation. Nature. 2019; 574:492&#x2013;493.</Citation><ArticleIdList><ArticleId IdType="pubmed">31645737</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang &#xa0;N., Wang &#xa0;W., Wang &#xa0;X., Mang &#xa0;G., Chen &#xa0;J., Yan &#xa0;X., Tong &#xa0;Z., Yang &#xa0;Q., Wang &#xa0;M., Chen &#xa0;L. &#xa0;et al. . &#xa0;Histone lactylation boosts reparative gene activation post-myocardial infarction. Circ. Res. &#xa0;2022; 131:893&#x2013;908.</Citation><ArticleIdList><ArticleId IdType="pubmed">36268709</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin-Requero &#xa0;A., Ayuso &#xa0;M.S., Parrilla &#xa0;R. &#xa0;Rate-limiting steps for hepatic gluconeogenesis. Mechanism of oxamate inhibition of mitochondrial pyruvate metabolism. J. Biol. Chem. &#xa0;1986; 261:13973&#x2013;13978.</Citation><ArticleIdList><ArticleId IdType="pubmed">3771515</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng &#xa0;Q., Wang &#xa0;K., Zhao &#xa0;Y., Ma &#xa0;Q., Chen &#xa0;Z., Huang &#xa0;W. &#xa0;Effects of the acetyltransferase p300 on tumour regulation from the novel perspective of posttranslational protein modification. Biomolecules. 2023; 13:417.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10046601</ArticleId><ArticleId IdType="pubmed">36979352</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakayama &#xa0;H., Ohuchida &#xa0;K., Yonenaga &#xa0;A., Sagara &#xa0;A., Ando &#xa0;Y., Kibe &#xa0;S., Takesue &#xa0;S., Abe &#xa0;T., Endo &#xa0;S., Koikawa &#xa0;K. &#xa0;et al. . &#xa0;S100P regulates the collective invasion of pancreatic cancer cells into the lymphatic endothelial monolayer. Int. J. Oncol. &#xa0;2019; 55:211&#x2013;222.</Citation><ArticleIdList><ArticleId IdType="pubmed">31180531</ArticleId></ArticleIdList></Reference><Reference><Citation>Stepp &#xa0;W.H., Meyers &#xa0;J.M., McBride &#xa0;A.A. &#xa0;Sp100 provides intrinsic immunity against human papillomavirus infection. mBio. 2013; 4:e00845-13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3892783</ArticleId><ArticleId IdType="pubmed">24194542</ArticleId></ArticleIdList></Reference><Reference><Citation>Collados&#xa0;Rodr&#xed;guez &#xa0;M. &#xa0;The fate of speckled protein 100 (Sp100) during herpesviruses infection. Front. Cell. Infect. Microbiol. &#xa0;2020; 10:607526.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7882683</ArticleId><ArticleId IdType="pubmed">33598438</ArticleId></ArticleIdList></Reference><Reference><Citation>Yordy &#xa0;J.S., Moussa &#xa0;O., Pei &#xa0;H., Chaussabel &#xa0;D., Li &#xa0;R., Watson &#xa0;D.K. &#xa0;SP100 inhibits ETS1 activity in primary endothelial cells. Oncogene. 2005; 24:916&#x2013;931.</Citation><ArticleIdList><ArticleId IdType="pubmed">15592518</ArticleId></ArticleIdList></Reference><Reference><Citation>Berscheminski &#xa0;J., Brun &#xa0;J., Speiseder &#xa0;T., Wimmer &#xa0;P., Ip &#xa0;W.H., Terzic &#xa0;M., Dobner &#xa0;T., Schreiner &#xa0;S. &#xa0;Sp100A is a tumor suppressor that activates p53-dependent transcription and counteracts E1A/E1B-55K-mediated transformation. Oncogene. 2016; 35:3178&#x2013;3189.</Citation><ArticleIdList><ArticleId IdType="pubmed">26477309</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernardi &#xa0;R., Pandolfi &#xa0;P.P. &#xa0;Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies. Nat. Rev. Mol. Cell Biol. &#xa0;2007; 8:1006&#x2013;1016.</Citation><ArticleIdList><ArticleId IdType="pubmed">17928811</ArticleId></ArticleIdList></Reference><Reference><Citation>Pearson &#xa0;M., Carbone &#xa0;R., Sebastiani &#xa0;C., Cioce &#xa0;M., Fagioli &#xa0;M., Saito &#xa0;S., Higashimoto &#xa0;Y., Appella &#xa0;E., Minucci &#xa0;S., Pandolfi &#xa0;P.P. &#xa0;et al. . &#xa0;PML regulates p53 acetylation and premature senescence induced by oncogenic Ras. Nature. 2000; 406:207&#x2013;210.</Citation><ArticleIdList><ArticleId IdType="pubmed">10910364</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu &#xa0;K.S., Guan &#xa0;B.J., Cheng &#xa0;X., Guan &#xa0;D., Lam &#xa0;M., Hatzoglou &#xa0;M., Kao &#xa0;H.Y. &#xa0;Translational control of PML contributes to TNF&#x3b1;-induced apoptosis of MCF7 breast cancer cells and decreased angiogenesis in HUVECs. Cell Death Differ. &#xa0;2016; 23:469&#x2013;483.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5072441</ArticleId><ArticleId IdType="pubmed">26383972</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>